Hemp THC Products: Delta-8, THCA and the 2026 Law

Delta-8 is still sold under the current federal hemp definition, but a growing number of states ban or restrict it. From 11 December 2026 the federal definition caps finished products at 0.4 mg total THC, plus similar-effect cannabinoids, per container and excludes synthesised cannabinoids, which would take most delta-8 products outside hemp. Check state law too.

The new federal hemp definition uses a total-THC standard, so THCA counts toward the limit alongside delta-9. Most THCA flower and many THCA products would therefore no longer qualify as hemp from 11 December 2026, and finished products also face the 0.4 mg per-container cap. Some states already apply stricter rules, so check local law.

Both are THC isomers that differ in the position of one double bond. Delta-9 is the main intoxicating compound in cannabis, while delta-8 occurs naturally only in small amounts, so most commercial delta-8 is made by chemically converting CBD. Controlled human data on delta-8 are limited, and both can trigger a positive THC drug test.

Under current law, most intoxicating hemp products lose federal hemp status on 11 December 2026, after H.R. 6500 pushed the change back from 12 November. Bills to delay further, repeal or regulate instead are pending, but none had passed committee as of 19 October 2026, and the White House says it will not support another delay.

Partly. In April 2026 DOJ and DEA moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III. Broader rescheduling of marijuana is still in process after a DEA hearing in September 2026. This change is separate from the hemp rules, which still take effect on 12 November and 11 December 2026.